Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Esophageal Stricture
Chemoradiotherapy can improve squamous cell carcinoma patient survival
April 22nd, 2003
Esophageal stricture due to malignant T3 and T4 squamous cell carcinoma can be resolved enough to increase patient survival somewhat by chemoradiotherapy. According to a study from Japan, "We retrospectively investigated the efficacy and feasibility of concurrent chemoradiotherapy for patients with severe dysphagia caused by esophageal squamous cell carcinoma. "Concurrent chemoradiotherapy was performed in 57 patients with T3 or T4 disease containing M1 lymph node (LYM) disease. Chemotherapy consisted of protracted infusion of 5-fluorouracil (5-FU) 400 mg/m2/24 h on days 1-5 and 8-12, combined with 2 h infusion of cisplatin (CDDP) 40...
Source: Cancer Weekly (2003-04-22)
|
